Memorial Sloane Ketterin Cancer Ctr — New York, New York

Memorial Sloane Ketterin Cancer Ctr is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloane Ketterin Cancer Ctr has participated in 3 clinical trials.

Therapeutic areas: Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC), KRAS G12-mutant NSCLC, Esophageal Squamous Cell Cancer (SCC).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloane Ketterin Cancer Ctr?

Memorial Sloane Ketterin Cancer Ctr has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloane Ketterin Cancer Ctr conducted?

Memorial Sloane Ketterin Cancer Ctr has 3 clinical trials on record. Their work covers Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC), KRAS G12-mutant NSCLC, Esophageal Squamous Cell Cancer (SCC).

Is Memorial Sloane Ketterin Cancer Ctr accredited by Crixeo Health?

Memorial Sloane Ketterin Cancer Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloane Ketterin Cancer Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.